RxDoctor Payments Data

Thomas Gilliland, MD

Cardiovascular Disease · Burlington, VTNPI 1093196065

Payments from drug & device makers

What this record shows

This record is dominated by grants: $30,000 of the $35,400 with a category attached, or 84.7%. 8 manufacturers reported payments, led by Medtronic at 46.0% of the total. Reporting peaked in 2024 at $33,411 and has fallen 96.7% since, to $1,103 in 2025.

$35,400in general payments, 2019–2025

Across 44 payments — averaging $804.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$16K
  • Boston Scientific$15K
  • Edwards Lifesciences$3K
  • Abbott$579
  • Cardiovascular Systems Inc.$159
  • International Life Sciences$108
  • plus $110 from 2 others

What the payments were for

  • Grants$30,00085%
  • Travel & lodging$2,6047%
  • Food & beverage$2,7958%
  • Education$10%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$35,400 in reported general payments places this provider in the 80th percentile of 27 cardiovascular disease providers in Vermont.

See all cardiovascular disease providers in Vermont

Medicare billing

Part B allowed, 2024
$30,126
Medicare patients
78
Services billed
200

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Burlington

See the full list for Vermont

Where these figures come from

Is this you, or does something look wrong? →